Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Part 3 of Medtech Insight’s feature series on the appraisal of manufacturing capability and maturity – “Medtech’s Next Top Maturity Model” – is discussed on this week’s podcast. Author Shawn M. Schmitt gives details on how Baxter Healthcare, Edwards Lifesciences and other firms weathered their appraisals using the Capability Maturity Model Integration (CMMI) model and method.
Device Week, July 6, 2018 – Clinical Data Presentations At ADA; Big Deals From GE, Novartis And Bio-Techne
In this edition of our weekly podcast, Medtech Insight editor Marion Webb reports on the American Diabetes Association conference in Orlando, Fla., and editor Reed Miller runs down the latest corporate restructuring news, including GE's decision to spin off GE Healthcare and Novartis giving-up on Alcon.
On this week's podcast, we discuss medtech matters that are on the radar of US lawmakers, and issues that are coming up in the courts.
On this week's podcast, we provide a roundup of recent guidance documents issued by US FDA on topics ranging from humanitarian use devices to off-label communications. We also discuss the Medtech Insight Awards.
In this edition of Device Week, Medtech Insight’s Tina Tan and Catherine Longworth discuss this year's trends in M&A and venture fundraising activity. They touch on what areas are getting the most interest from investors and strategic buyers, and the most recent deals worth noting.
In this week's podcast, we discuss the upcoming Medtech Insight Awards, digital-health recommendations, an uptick in device cybersecurity alerts from the US Department of Homeland Security, and a nascent FDA program to improve use of standards in pre-market submissions.
On this week's podcast, Catherine Longworth reports on the the SPYRAL HTN-ON MED pilot study results presented at the EuroPCR 2018 conference in Paris. The results of the sham-controlled trial showed that Medtronic's Symplicity Spyral renal denervation system can significantly reduce blood pressure in hypertension patients on hypertension medications.
On this week’s podcast, part 2 of our multi-part Medtech Insight feature series on the appraisal of manufacturing capability and maturity – “Medtech’s Next Top Maturity Model” – is discussed. Author Shawn M. Schmitt explains what happens when a device-maker is appraised using the Capability Maturity Model Integration (CMMI) model and method, from the first intake calls to the last day of the assessment, when the final appraisal results are given to a firm.
On this week's podcast, Shawn M. Schmitt talks about his first story in a multi-part Medtech Insight feature series on the appraisal of manufacturing capability and maturity, and what it means for the medical device industry. An ongoing US FDA pilot program – which uses an industry-tailored version of the Capability Maturity Model Integration (CMMI) model and method – is discussed.
On this week’s podcast, Marion Webb reports on emerging exoskeleton technology to help patients recovering from spinal cord injuries or stroke, and Catherine Longworth reports on BioTrinity 2018 in London, a gathering of investors and medtech innovators.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.